AzTrials
AzTrials

Vomiting, PostoperativePhase 3NCT03104023

Staple Line Inversion vs Buttressing on Postoperative Vomits After LSG

A Phase 3 study testing Staple line inversion and Staple line buttressing in people with Vomiting, Postoperative, run by Hospital General Universitario Elche at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Patients undergoing laparoscopic sleeve gastrectomy will be randomized into 2 groups. In one group, a staple line inversion with a running suture of Polypropylene will be performed. Read more about this study

Who is it for?
Any age
Conditions the study is for
Vomiting, Postoperative
What is being tested?
Staple line inversion and Staple line buttressing
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteSpain
Study dates
Jan 2017to Aug 2017
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • BMI >40
  • BMI>35 with obesity-related comorbidities

Who cannot join

  • Patients undergoing other bariatric techniques than sleeve gastrectomy
  • Laparotomic approach

Trial locations and contacts

1 site in 1 country.

Lorea Zubiaga, MD, PhD contact

obesidadhospitalgeneralelche@gmail.com

Maria Diez, MD, PhD contact

neuroestimulacionobesidad@gmail.com

Spain1 site, 1 recruiting
  • Hospital general Universitario de Elche

    Elche, Alicante, 03202

    Jaime Ruiz-Tovar, MD, PhD, 0034-630534808, jruiztovar@gmail.com

    Recruiting

Other trials in Spain

About this study

Official title: Influence of Staple Line Inversion vs Buttressing on Postoperative Nausea or Vomits After Laparoscopic Sleeve Gastrectomy (LSG)

Patients undergoing laparoscopic sleeve gastrectomy will be randomized into 2 groups. In one group, a staple line inversion with a running suture of Polypropylene will be performed. In the second group, the gastric section will be performed with a stapler with preloaded buttress material

Postoperative nausea and vomits during the first 24 hours will be investigated.

Read the detailed description

Patients undergoing laparoscopic sleeve gastrectomy as bariatric procedure will be randomized into 2 groups. In one group after the stapling and section of the stomach with stapling devices (EndoGIA, Covidien, USA), a staple line inversion with hemostatic and aims will be performed. Staple line inversion will be performed with a running suture of Polypropylene 2/0. In the second group, the gastric section will be performed with a stapler with preloaded buttress material (EndoGIA with reinforced reload, Covidien, USA).

Postoperative nausea and vomits during the first 24 hours after surgery will be investigated.

Being tested
Staple line inversion, Staple line buttressing
Medical subject headings
Postoperative Nausea and Vomiting

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Staple line inversionProcedure or surgery

    A staple line inversion will be performed with a running suture of Polypropylene 2/0

  • Staple line buttressingCombination product

    The gastric section will be performed with a stapler with preloaded buttress material

Study groups in NCT03104023
Study groupRoleWhat they receive
Staple line inversionActive comparatorPatients will undergo a staple line inversion with a a running suture of Polypropylene 2/0.
Receives: Procedure: Staple line inversion
Staple line buttressingExperimentalThe gastric section will be performed with preloaded buttress material .
Receives: Combination Product: Staple line buttressing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative nausea and vomits

    Postoperative nausea and vomits will be measured using the postoperative nausea and vomiting intensity scale, described by Wengritzky et al (Br J Anaesth 2010;104:158-166). In this scale, the number of vomits are quantified, the frequence of nausea and if it is constant or varying are determined, and the duration of the feeling of nausea is established.

    Measured: 24 hours after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Apr 2017
  2. Study startJan 2017
  3. Primary completionAug 2017 (estimated)
  4. Study completionAug 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03104023
Sponsor's protocol ID
HGUE 2016-33
Status last verified
Mar 2017
First submitted
24 Mar 2017
Last updated
27 Jun 2017
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Staple line inversion and Staple line buttressing in people with Vomiting, Postoperative, run by Hospital General Universitario Elche at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 27 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Lorea Zubiaga, MD, PhD (obesidadhospitalgeneralelche@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative nausea and vomits (time frame: 24 hours after surgery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jun 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in